Biopesticides developer Vestaron is ramping up commercialization efforts for its current products, but the company isn’t neglecting the R&D that could lead to new ones. Here’s what’s happening.
Read More
Agtech startup Vestaron, which aims to prove its biological-based pesticides don’t trade efficacy for safety vs. chemical products, has added another $10 million to its warchest.
Read More
Agtech startup Vestaron is showing that it is gaining more traction with investors. Vestaron has raised $82 million in financing to support commercialization of its current product lineup and fuel the R&D of new products.
Read More
Agtech startup Vestaron has closed on an $82 million round of capital in a Series C round, the company disclosed Monday.
Read More
Three high-profile startup CEOs will speak at CED Venture Connect Summit next week in a session called “Growth Stories”. Each CEO will join the stage with one of their investment partners to discuss recent fundraising. But we have a sneak preview of the wisdom they’ve gained and the lessons they’ve learned.
Read More
Agtech startup Vestaron is looking to raise $101 million and already has 13 backers in the round, according to an SEC filing. Here’s the latest.
Read More
Some of Mexico’s signature crops could soon be protected from pests with a product developed by a North Carolina company. Regulatory authorities south of the border have approved Vestaron’s SPEAR-Lep, a biopesticide that’s already in use in the U.S.
Read More
Vestaron’s Spear line of products showed how peptides can point the way to control of crop pests in a way that’s safe for people, beneficial insects, and the environment. Now the biopesticides startup is making progress toward bringing growers a second line of products that work in a similar manner.
Read More
Vestaron has a unique, peptide-based pesticide that is environmentally safe and just as effective as less environmentally friendly synthetics. In a market hungry for innovation, its first year’s sales despite pandemic headwinds, impressed investors who oversubscribed its new financing.
Read More
